Abstract: A processor of a wearable device is provided. The processor includes obtaining posture information of the wearable device in a space including the wearable device, based on classification information for selecting at least one feature point within pixels based on differences between pixels included in a first frames output from a first camera, identifying resolutions of each of a plurality of areas included in field-of-view (FoV) formed based on a display, based on the number of feature points obtained in each of the plurality of areas by the classification information, and changing resolution, among resolutions identified based on gaze information indicating gaze of user wearing the wearable device, corresponding to a first area, among a plurality of areas, to resolution larger than resolution corresponding to second area.

Abstract: A device including an interface with peripherals includes a first interface that receives a request from a host, a second interface that periodically receives at least one first sample input from the peripherals in response to the request from the host, a memory that stores an active time table including a processing time of a sample input provided by each of the peripherals in each of a plurality of operating conditions respectively corresponding to different power consumptions, and a processing circuit that identifies at least one of the plurality of operating conditions based on the active time table and a period of the at least one first sample input.

Abstract: A method of manufacturing a gas sensor for detecting xylene is provided. A method of manufacturing a gas sensor includes reacting a mixed material including a first material containing a cobalt (Co) element and a second material containing a chromium (Cr) element to form a CoCr2O4 hollow structure having a hollow shape.

Abstract: This disclosure relates to oligonucleotides, compositions and methods useful for reducing LDHA expression, particularly in hepatocytes.

Abstract: In accordance with a first aspect of the present disclosure, a communication device is provided, comprising: an ultra-wideband (UWB) communication unit configured to enable UWB communication with at least one external communication device; a processing unit configured to perform a ranging session between the communication device and the external communication device, wherein said ranging session comprises one or more distance measurements based on messages exchanged between the communication device and the external communication device, wherein said messages are exchanged through the UWB communication unit; a prioritization unit configured to prioritize said ranging session using a synchronization indicator associated with said ranging session. In accordance with a second aspect of the present disclosure, a corresponding method of operating a communication device is conceived. In accordance with a third aspect of the present disclosure, a computer program is provided for carrying out said method.

Abstract: A display module bending apparatus includes: a stage on which a display module including a display panel and a circuit board is seated; a bending arm which fixes the circuit board and bending the circuit board based on a first reference; a first measuring unit which measures first information; a second measuring unit disposed on the stage and which measures second information; and a control unit which compensates the first reference based on the first information and the second information.

Abstract: An illumination apparatus includes a main light source, a half mirror, and a diffusion plate. The main light source emits main light. The half mirror is spaced apart from the main light source. The half mirror reflects a first light travelling in a first direction among the main light source. The half mirror has a reflective surface reflecting the first light to travel in a second direction. The diffusion plate is disposed between the main light source and the half mirror not overlapping the reflective surface. The diffusion plate has a first horizontal surface and a second horizontal surface. The second horizontal surface is a rear surface of the first horizontal surface. The diffusion plate transmits a second light incident on the first horizontal surface among the main light. The diffusion plate scatters the second light from the second horizontal surface.

Abstract: An illumination apparatus includes a main light source, a half minor, and a diffusion plate. The main light source emits main light. The half mirror is spaced apart from the main light source. The half mirror reflects a first light travelling in a first direction among the main light source. The half mirror has a reflective surface reflecting the first light to travel in a second direction. The diffusion plate is disposed between the main light source and the half mirror not overlapping the reflective surface. The diffusion plate has a first horizontal surface and a second horizontal surface. The second horizontal surface is a rear surface of the first horizontal surface. The diffusion plate transmits a second light incident on the first horizontal surface among the main light. The diffusion plate scatters the second light from the second horizontal surface.

Abstract: This disclosure relates to oligonucleotides, compositions and methods useful for reducing LDHA expression, particularly in hepatocytes.

Abstract: A device including an interface with peripherals includes a first interface that receives a request from a host, a second interface that periodically receives at least one first sample input from the peripherals in response to the request from the host, a memory that stores an active time table including a processing time of a sample input provided by each of the peripherals in each of a plurality of operating conditions respectively corresponding to different power consumptions, and a processing circuit that identifies at least one of the plurality of operating conditions based on the active time table and a period of the at least one first sample input.

Abstract: Provided are a display apparatus, and a method and system for controlling the same, the display apparatus including: a display; an interface; a storage; and a processor configured to transmit information on a refresh rate of the display, stored in the storage, to a source apparatus connected to the interface; based on an image signal received from the source apparatus being displayed as an image on the display at a preset first refresh rate for more than a predetermined period, switch the refresh rate, stored in the storage, to a second refresh rate that is lower than the first refresh rate; transmit information about the second refresh rate to the source apparatus; and display the image on the display at the second refresh rate of the image signal received from the source apparatus.

Abstract: This disclosure relates to oligonucleotides, compositions and methods useful for reducing LDHA expression, particularly in hepatocytes.

Abstract: This disclosure relates to oligonucleotides, compositions and methods useful for reducing LDHA expression, particularly in hepatocytes.

Abstract: A method of manufacturing a gas sensor for detecting xylene is provided. A method of manufacturing a gas sensor includes reacting a mixed material including a first material containing a cobalt (Co) element and a second material containing a chromium (Cr) element to form a CoCr2O4 hollow structure having a hollow shape.

Abstract: Provided are a display apparatus, and a method and system for controlling the same, the display apparatus including: a display; an interface; a storage; and a processor configured to transmit information on a refresh rate of the display, stored in the storage, to a source apparatus connected to the interface; based on an image signal received from the source apparatus being displayed as an image on the display at a preset first refresh rate for more than a predetermined period, switch the refresh rate, stored in the storage, to a second refresh rate that is lower than the first refresh rate; transmit information about the second refresh rate to the source apparatus; and display the image on the display at the second refresh rate of the image signal received from the source apparatus.

Abstract: Disclosed herein is a method for inhibiting expression of a gene of a subject comprising administering (1) a composition comprising R-(L)a-(G)b; wherein R is an oligonucleotide selected from the group consisting of DNA, RNA, siRNA, and microRNA; L is a linker and each occurrence of L is independently selected from Table 3; G is a targeting ligand and each occurrence of G is independently selected from Table 4; each of a and b is independently 0, 1, 2, 3 or 4; and (2) a composition comprising (P)c-(L)d-(G)e; wherein P is a peptide and each occurrence of P is independently selected from Table 2; L is a linker and each occurrence of L is independently selected from Table 3; G is a targeting ligand and each occurrence of G is independently selected from Table 4; d is 0, 1, 2, 3, 4, 5 or 6; and each of c and e is independently 1, 2, 3, 4, 5 or 6. Compositions in (1) and (2) can be co-administered or sequentially administered.

Abstract: Disclosed herein is a peptide containing conjugate comprising (P)c-(L)d-(G)e, wherein P is a peptide and each occurance of P is independently selected from Table 2; L is an optional linker and each occurance of L, if present, is independently selected from Table 3; G is a targeting ligand and each occurance of G is independently selected from Table 4; d is 0, 1, 2, 3, 4, 5 or 6; and each of c and e is independently 1, 2, 3, 4, 5 or 6. The conjugate can be administered to a subject either alone or in combination with a composition comprising R-(L)a-(G)b, wherein R is an oligonucleotide as defined herein, to inhibit expression of a gene of the subject.

Abstract: Disclosed herein is a method for inhibiting expression of a gene of a subject comprising administering (1) a composition comprising R-(L)a-(G)b; wherein R is an oligonucleotide selected from the group consisting of DNA, RNA, siRNA, and microRNA; L is a linker and each occurance of L is independently selected from Table 3; G is a targeting ligand and each occurance of G is independently selected from Table 4; each of a and b is independently 0, 1, 2, 3 or 4; and (2) a composition comprising (P)c-(L)d-(G)e; wherein P is a peptide and each occurance of P is independently selected from Table 2; L is a linker and each occurance of L is independently selected from Table 3; G is a targeting ligand and each occurance of G is independently selected from Table 4; d is 0, 1, 2, 3, 4, 5 or 6; and each of c and e is independently 1, 2, 3, 4, 5 or 6. Compositions in (1) and (2) can be co-administered or sequentially administered.

Abstract: Disclosed herein is a method for inhibiting expression of a gene of a subject comprising administering (1) a composition comprising R-(L)a-(G)b; wherein R is an oligonucleotide selected from the group consisting of DNA, RNA, siRNA, and microRNA; L is a linker and each occurrence of L is independently selected from Table 3; G is a targeting ligand and each occurrence of G is independently selected from Table 4; each of a and b is independently 0, 1, 2, 3 or 4; and (2) a composition comprising (P)c-(L)d-(G)e; wherein P is a peptide and each occurrence of P is independently selected from Table 2; L is a linker and each occurrence of L is independently selected from Table 3; G is a targeting ligand and each occurrence of G is independently selected from Table 4; d is 0, 1, 2, 3, 4, 5 or 6; and each of c and e is independently 1, 2, 3, 4, 5 or 6. Compositions in (1) and (2) can be co-administered or sequentially administered.

Abstract: Disclosed herein is a method for inhibiting expression of a gene of a subject comprising administering (1) a composition comprising R-(L)a-(G)b; wherein R is an oligonucleotide selected from the group consisting of DNA, RNA, siRNA, and microRNA; L is a linker and each occurrence of L is independently selected from Table 3; G is a targeting ligand and each occurrence of G is independently selected from Table 4; each of a and b is independently 0, 1, 2, 3 or 4; and (2) a composition comprising (P)c-(L)d-(G)e; wherein P is a peptide and each occurrence of P is independently selected from Table 2; L is a linker and each occurrence of L is independently selected from Table 3; G is a targeting ligand and each occurrence of G is independently selected from Table 4; d is 0, 1, 2, 3, 4, 5 or 6; and each of c and e is independently 1, 2, 3, 4, 5 or 6. Compositions in (1) and (2) can be co-administered or sequentially administered.